Michael F Cola - Net Worth and Insider Trading
Michael F Cola Net Worth
The estimated net worth of Michael F Cola is at least $467,156 dollars as of 2024-04-27. Michael F Cola is the President and CEO of Aevi Genomic Medicine Inc and owns about 2,267,859 shares of Aevi Genomic Medicine Inc (GNMX) stock worth over $376,238. Michael F Cola is the Director of Phathom Pharmaceuticals Inc and owns about 9,798 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $89,946. Michael F Cola is also the CEO of Avalo Therapeutics Inc and owns about 61 shares of Avalo Therapeutics Inc (AVTX) stock worth over $972. Details can be seen in Michael F Cola's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael F Cola has not made any transactions after 2020-06-09 and currently still holds the listed stock(s).
Transaction Summary of Michael F Cola
Michael F Cola Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael F Cola owns 6 companies in total, including Avalo Therapeutics Inc (AVTX) , Aevi Genomic Medicine Inc (GNMX) , and Sage Therapeutics Inc (SAGE) among others .
Click here to see the complete history of Michael F Cola’s form 4 insider trades.
Insider Ownership Summary of Michael F Cola
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2020-06-09 | director & Chief Executive Officer |
| GNMX | Aevi Genomic Medicine Inc | 2020-06-09 | director & Chief Executive Officer |
| SAGE | Sage Therapeutics Inc | 2014-09-11 | director |
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | director |
| VNDA | Vanda Pharmaceuticals Inc | 2018-06-13 | director |
| SFES | Safeguard Scientifics Inc | 2004-01-12 | Managing Director |
Michael F Cola Latest Holdings Summary
Michael F Cola currently owns a total of 3 stocks. Among these stocks, Michael F Cola owns 2,267,859 shares of Aevi Genomic Medicine Inc (GNMX) as of December 5, 2019, with a value of $376,238 and a weighting of 80.54%. Michael F Cola owns 9,798 shares of Phathom Pharmaceuticals Inc (PHAT) as of October 29, 2019, with a value of $89,946 and a weighting of 19.25%. Michael F Cola also owns 61 shares of Avalo Therapeutics Inc (AVTX) as of June 9, 2020, with a value of $972 and a weighting of 0.21%.
Latest Holdings of Michael F Cola
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNMX | Aevi Genomic Medicine Inc | 2019-12-05 | 2,267,859 | 0.17 | 376,238 |
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | 9,798 | 9.18 | 89,946 |
| AVTX | Avalo Therapeutics Inc | 2020-06-09 | 61 | 15.94 | 972 |
Holding Weightings of Michael F Cola
Michael F Cola Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael F Cola has made a total of 1 transactions in Aevi Genomic Medicine Inc (GNMX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aevi Genomic Medicine Inc is the acquisition of 2,049,376 shares on December 5, 2019, which cost Michael F Cola around $266,419.
According to the SEC Form 4 filings, Michael F Cola has made a total of 1 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Phathom Pharmaceuticals Inc is the acquisition of 9,798 shares on October 29, 2019, which cost Michael F Cola around $186,162.
According to the SEC Form 4 filings, Michael F Cola has made a total of 2 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 35 shares on June 9, 2020, which cost Michael F Cola around $250,000.
Insider Trading History of Michael F Cola
- 1
Michael F Cola Trading Performance
GuruFocus tracks the stock performance after each of Michael F Cola's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael F Cola is 12.82%. GuruFocus also compares Michael F Cola's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael F Cola within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael F Cola's insider trading performs compared to the benchmark.
Performance of Michael F Cola
Average Return
31.11%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.69 | 12.82 | 19.97 | 31.11 | -46.32 | -41.73 |
| Relative Return to S&P 500(%) | 6.79 | 5.51 | 12.08 | 10.64 | -60.12 | -51.47 |
Michael F Cola Ownership Network
Ownership Network List of Michael F Cola
Ownership Network Relation of Michael F Cola
Michael F Cola Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Michael F Cola is the director & Chief Executive Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Michael F Cola made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Michael F Cola Mailing Address
Above is the net worth, insider trading, and ownership report for Michael F Cola. You might contact Michael F Cola via mailing address: 435 Devon Park Building 800, Wayne Pa 19087-1945.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
